These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
812 related articles for article (PubMed ID: 24857547)
1. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Ferrer CM; Lynch TP; Sodi VL; Falcone JN; Schwab LP; Peacock DL; Vocadlo DJ; Seagroves TN; Reginato MJ Mol Cell; 2014 Jun; 54(5):820-31. PubMed ID: 24857547 [TBL] [Abstract][Full Text] [Related]
2. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α. Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378 [TBL] [Abstract][Full Text] [Related]
3. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells. Sermikli BP; Aydogdu G; Yilmaz E Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273 [TBL] [Abstract][Full Text] [Related]
4. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer. Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967 [TBL] [Abstract][Full Text] [Related]
5. Glucosamine-induced Sp1 O-GlcNAcylation ameliorates hypoxia-induced SGLT dysfunction in primary cultured renal proximal tubule cells. Suh HN; Lee YJ; Kim MO; Ryu JM; Han HJ J Cell Physiol; 2014 Oct; 229(10):1557-68. PubMed ID: 24591095 [TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation of eIF2α regulates the phospho-eIF2α-mediated ER stress response. Jang I; Kim HB; Seo H; Kim JY; Choi H; Yoo JS; Kim JW; Cho JW Biochim Biophys Acta; 2015 Aug; 1853(8):1860-9. PubMed ID: 25937070 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904 [TBL] [Abstract][Full Text] [Related]
8. O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway. Ferrer CM; Lu TY; Bacigalupa ZA; Katsetos CD; Sinclair DA; Reginato MJ Oncogene; 2017 Jan; 36(4):559-569. PubMed ID: 27345396 [TBL] [Abstract][Full Text] [Related]
9. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells. de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830 [TBL] [Abstract][Full Text] [Related]
10. Feedback Regulation of Lin CH; Liao CC; Chen MY; Chou TY Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653 [TBL] [Abstract][Full Text] [Related]
11. Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity. Narayanan B; Sinha P; Henry R; Reeves RA; Paolocci N; Kohr MJ; Zachara NE J Biol Chem; 2023 Dec; 299(12):105447. PubMed ID: 37949223 [TBL] [Abstract][Full Text] [Related]
12. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Butkinaree C; Park K; Hart GW Biochim Biophys Acta; 2010 Feb; 1800(2):96-106. PubMed ID: 19647786 [TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy. Xu C; Liu G; Liu X; Wang F Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041 [TBL] [Abstract][Full Text] [Related]
14. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356 [TBL] [Abstract][Full Text] [Related]
15. Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy. Kim G; Cao L; Reece EA; Zhao Z Sci Rep; 2017 Sep; 7(1):11107. PubMed ID: 28894244 [TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation in cancer development and immunotherapy. He XF; Hu X; Wen GJ; Wang Z; Lin WJ Cancer Lett; 2023 Jul; 566():216258. PubMed ID: 37279852 [TBL] [Abstract][Full Text] [Related]
17. O-GlcNAcylation of RBM14 contributes to elevated cellular O-GlcNAc through regulation of OGA protein stability. Kweon TH; Jung H; Ko JY; Kang J; Kim W; Kim Y; Kim HB; Yi EC; Ku NO; Cho JW; Yang WH Cell Rep; 2024 May; 43(5):114163. PubMed ID: 38678556 [TBL] [Abstract][Full Text] [Related]
18. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification. Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436 [TBL] [Abstract][Full Text] [Related]
19. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation. Nagel AK; Ball LE Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147 [TBL] [Abstract][Full Text] [Related]
20. Essential role of O-GlcNAcylation in stabilization of oncogenic factors. Makwana V; Ryan P; Patel B; Dukie SA; Rudrawar S Biochim Biophys Acta Gen Subj; 2019 Aug; 1863(8):1302-1317. PubMed ID: 31034911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]